Dr. Shalhav named chief of urology at University of Chicago
May 21st 2007Arieh Shalhav, MD, has been named permanent section chief for urology at the University of Chicago Medical Center. Dr. Shalhav, who has served as interim urology section chief for the department of surgery since last July, is a recognized authority on minimally invasive urologic surgery, and is director of the university?s minimally invasive urology program and fellowship.
EMR is specifically tailored to needs of urologists
May 21st 2007AllMeds (Oak Ridge, TN) has introduced a new addition to its line of electronic medical records systems specifically created for urology practices. The EMR for Urology contains clinical content to allow urologists to increase revenue through more accurate E&M coding and reimbursement levels, efficiency gains through workflow management and decision support tools, and greater audit protection due to improved encounter documentation, the company says.
5-, 10-day regimens show similar efficacy in acute UTIs, pyelonephritis
May 21st 2007A once-daily, 5-day course of levofloxacin (Levaquin) is equally effective as standard 10-day, twice-daily treatment with ciprofloxacin (Cipro) in the treatment of complicated urinary tract infections and acute pyelonephritis, according to study data reported at the AUA annual meeting.
TRT in middle-aged hypogonadal men: Vigilance advised
May 21st 2007The authors of a study from the University of North Carolina, Chapel Hill, suggest that physicians treating middle-aged hypogonadal men with extrinsic testosterone should be more vigilant in monitoring these patients' PSA levels than they would be in monitoring non-hypogonadal men of the same age.
Outcomes comparable for cryo, EBRT in prostate cancer
May 21st 2007After nearly 7 years of follow-up, cryoablation appears to be as effective as external beam radiation therapy (EBRT) in the treatment of localized prostate cancer, according to the results of a prospective, randomized trial by researchers at the University of Calgary, Alberta, Canada.
Voiding symptoms common in women planning SUI surgery
May 21st 2007Voiding symptoms are common in women who are planning incontinence surgery, even if they have no prior history of incontinence procedures. That is just one of the surprises from the Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr), the largest randomized study of female incontinence surgery ever performed.
AUA 2007 Annual Meeting: Podcast - Day Two
May 20th 2007Listen to the Urology Times Radio podcast from Day Two of the 2007 AUA Annual Meeting in Anaheim, California. This podcast includes interviews with highly regarded experts in urological medicine including: Anthony D'Amico, MD, discusses ADT and the associated risk of cardiac mortality Brent Yanke, MD, talks about endoscopic treatment of low-grade TCCJ. Stuart Wolf, MD, discusses the expansion and contraction of U.S. urologic practice
New, simple test may help detect bladder cancer
May 20th 2007Researchers at the Friedrich Schiller University of Jena, Germany, are exploring the potential of oncofetal fibronectin (fFN) as a potential new marker for bladder cancer. If successful, the test would be a simple urine dipstick test involving a monitor that measures the concentration of the protein in a sample. It would produce results in about 20 minutes.
Study finds ADT increases risk of new-onset diabetes
May 20th 2007Initiating androgen deprivation therapy (ADT) in men with prostate cancer significantly increases the risk of incident diabetes, and that effect occurs within a relatively short time frame, according to research presented here yesterday.
Declining PCa mortality correlates to increased rates of high cholesterol
May 20th 2007A search for reasons behind the decline in prostate cancer mortality since the mid-1990s revealed two of the usual suspects-PSA screening and access to health insurance-but also uncovered an unlikely and totally unexpected lipid factor.
Leading center finds outcomes of lap, open RP comparable
May 20th 2007When performed by the hands of experienced prostate cancer surgeons at a center of excellence, laparoscopic radical prostatectomy (LRP) and open retropubic radical prostatectomy (RRP) are associated with comparable outcomes in the treatment of clinically localized prostate cancer, according to findings reported by urologists from Memorial Sloan-Kettering Cancer Center in New York.
Endoscopy effective in some patients with upper-tract TCC
May 20th 2007Patients with a relatively small volume of low-grade, upper-tract transitional cell carcinoma can be managed by purely endoscopic means over a long period of time, surgeons from Thomas Jefferson University, Philadelphia, reported here.
ADT identified as independent risk factor for fatal CVD events
May 20th 2007Androgen deprivation therapy (ADT) delivered in conjunction with surgery, radiation therapy, or cryotherapy for localized prostate cancer appears to significantly increase the risk of fatal cardiovascular (CVD) events among men 65 years and older. The increased risk is maintained after adjusting for most known coronary artery disease (CAD) risk factors and increases with increasing duration of therapy, but is present in men receiving as little as 3 months of ADT, according to the findings of a retrospective study reported yesterday at the AUA annual meeting.
Research disputes link between infection, catheter placement after injury
May 19th 2007Adding new data to the controversy involving urology and orthopedics, a review of trauma-associated posterior urethral distraction injury revealed a post-treatment infection rate of 8.8% in men who received suprapubic catheters with orthopedic intervention for pelvic fractures.
AUA celebrates Excellence in Urology reporting
May 19th 2007AUA paid tribute to outstanding health journalism by presenting the first Excellence in Urology Health Reporting Awards at a press reception yesterday. Eric T. Rosenthal received the Trade Press award for his Oncology Times article, "Prostate Cancer: Pros and Cons of the Integration of Urology and IMRT Services in the Community Practice." MSNBC reporter Michael Stuckey took the Consumer Broadcast award for his series, "Low Blow: One Man's Battle with Prostate Cancer."
Robotic microscopy expedites bladder Ca diagnosis
May 19th 2007The oncoFISH Bladder robotic digital microscopy system from Ikonisys (New Haven, CT) identifies and measures aneuploidy on chromosomes 3, 7, 9, and 17 in urine sediment specimens for diagnosis of initial and recurrent bladder cancer. Up to 170 prepared slides can be loaded, scanned, and the images captured in this walkaway system, which generates a gallery of images for review and interpretation. Select slide images and the analytical report can be transmitted to the urologist within 24 hours for diagnosis.
Genes in pathogenic E. coli may suppress, not exacerbate, inflammation
May 19th 2007Some patients may be especially susceptible to urinary tract infections, and some uropathogens may be particularly virulent. But that's not the whole story. Virulent bacteria, in fact, may actually change their hosts' immune systems to break through their defenses.
Urologic diseases in U.S. run up $11 billion annual tab
May 19th 2007Americans spend almost $11 billion annually in medical care related to urologic diseases, and Medicare's share of the bill was $5.4 billion, according to a 5-year project issued by the National Institutes of Health that is now available in print and on CD.
Relationship seen between chronic inflammation and LUTS
May 19th 2007Preliminary results from the REDUCE (REduction by DUtasteride of prostate Cancer Events) trial suggest a relationship between the degree of chronic inflammation and LUTS, but not clinical prostatitis-like symptoms in the REDUCE population. Also, men with more severe LUTS are more likely to experience pelvic pain as part of their symptom complex, according to the study findings presented here yesterday.
Minimally invasive urologic surgery is successful in kids
May 15th 2007It appears that ureteroscopy and other minimally invasive techniques, such as laser lithotripsy, are safe and effective in managing pediatric nephrolithiasis, including ureteric calculi, renal pelvic stones, and lower-pole stones.